Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.725
-0.045 (-5.83%)
At close: Nov 4, 2024, 4:00 PM
0.750
+0.025 (3.45%)
After-hours: Nov 4, 2024, 7:32 PM EST
Vaxart Employees
Vaxart had 109 employees as of December 31, 2023. The number of employees decreased by 55 or -33.54% compared to the previous year.
Employees
109
Change (1Y)
-55
Growth (1Y)
-33.54%
Revenue / Employee
$127,780
Profits / Employee
-$694,110
Market Cap
164.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 987 |
BrainsWay | 134 |
Atai Life Sciences | 83 |
Acumen Pharmaceuticals | 52 |
Atossa Therapeutics | 12 |
Sagimet Biosciences | 10 |
Inhibikase Therapeutics | 9 |
Akso Health Group | 9 |
VXRT News
- 5 weeks ago - Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate - GlobeNewsWire
- 2 months ago - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside - Benzinga
- 3 months ago - Vaxart, Inc. (VXRT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vaxart Provides Business Update and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8 - GlobeNewsWire
- 4 months ago - Vaxart Inc: Asymmetric Risk-Reward Opportunity Following BARDA Funding - Seeking Alpha
- 5 months ago - Vaxart Provides Business Update - GlobeNewsWire